
Brian Culley, CEO of Lineage Cell Therapeutics $LCTX Joins Us To Discuss Top Line Results For AMD
05/07/21 • 32 min
https://www.youtube.com/watch?v=UE9xwEbImwo&t=104s
https://www.youtube.com/watch?v=UE9xwEbImwo&t=104s
Previous Episode

Corcept Therapeutics Incorporated (CORT) Stock Analysis: Hyperfocused and Poised For Growth!
Corcept Therapeutics Incorporated (CORT) Stock Analysis: Hyperfocused and Poised For Growth! Article: https://www.latinosinclinicalresearch.com/written-articles/can-company-sustain-huge-growth-rate
Next Episode

Oncologist Convinced To Buy $GOVX and Hold Long Term. Small Cap With HUGE Potential in Vaccines!
Oncologist Convinced To Buy $GOVX and Hold Long Term. Small Cap With HUGE Potential in Vaccines!
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/the-clinical-research-circle-108654/brian-culley-ceo-of-lineage-cell-therapeutics-lctx-joins-us-to-discuss-13631384"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to brian culley, ceo of lineage cell therapeutics $lctx joins us to discuss top line results for amd on goodpods" style="width: 225px" /> </a>
Copy